| NCT ID | NCT07243821 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Metabolic Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2025-10-31 |
| Primary Completion | 2028-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2025-10-31 with a primary completion date of 2028-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to establish a cohort of individuals with metabolic syndrome and prediabetes to enable long-term follow-up of risk factors, disease progression, and the development of obesity-related complications. The study will also monitor changes in nutritional status and physical function over time, in order to identify key prognostic determinants influencing clinical outcomes. Metabolic syndrome and prediabetes are chronic multisystem disorders, and poor long-term control is closely associated with the development of various complications. Moreover, malnutrition and functional decline are common comorbid conditions that further impair quality of life and impose a substantial burden on healthcare resources.
Eligibility Criteria
Inclusion Criteria 1. Adults aged 18 years or older. 2. Individuals clinically diagnosed by a physician as having metabolic syndrome (meeting at least three of the following five criteria) or prediabetes: (A) Waist circumference: ≥ 90 cm in men or ≥ 80 cm in women, or body mass index (BMI) ≥ 27 kg/m². (B) Fasting plasma glucose (AC): ≥ 100 mg/dL. (C) Blood pressure: Systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg. (D) Triglycerides (TG): ≥ 150 mg/dL. (E) High-density lipoprotein cholesterol (HDL-C): \< 40 mg/dL in men or \< 50 mg/dL in women. 3. Individuals meeting the definition of prediabetes, defined as glycated hemoglobin (HbA1c) between 5.7% and 6.4%. 4. Participants who are willing to participate in the study and have signed written informed consent. 5. Participants who are able to complete basic physical examinations and assessment procedures. Exclusion Criteria 1. Individuals unable to comprehend the study information or procedures. 2. Individuals unable to comply with the required assessments or study protocols. 3. Any other condition that, in the clinical judgment of the principal investigator, deems the individual unsuitable for participation.
Contact & Investigator
Chia-Wen Lu, Present Professor
STUDY CHAIR
Department of Family Medicine, National Taiwan University Hospital
Frequently Asked Questions
Who can join the NCT07243821 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Metabolic Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07243821 currently recruiting?
Yes, NCT07243821 is actively recruiting participants. Contact the research team at biopsycosocial@gmail.com for enrollment information.
Where is the NCT07243821 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT07243821 clinical trial?
NCT07243821 is sponsored by National Taiwan University Hospital. The principal investigator is Chia-Wen Lu, Present Professor at Department of Family Medicine, National Taiwan University Hospital. The trial plans to enroll 2,000 participants.